Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 286, Issue 51, Pages 44005-44014Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M111.254995
Keywords
-
Categories
Funding
- National Institutes of Health [R01DK58096]
- Wellcome Trust [081958/Z/07/Z]
- European Community [FP7/2007-2013, 115005]
- Servier IdS
- French Agence Nationale de la Recherche [ANR-08-GENOPAT]
- Contrat de Projets Etat-Region Nord-Pas-De-Calais [CPER 2007-2013]
- Fonds de Recherche en Sante du Quebec
- Royal Society
- Medical Research Council [G0401641] Funding Source: researchfish
- MRC [G0401641] Funding Source: UKRI
Ask authors/readers for more resources
PAS kinase (PASK) is a glucose-regulated protein kinase involved in the control of pancreatic islet hormone release and insulin sensitivity. We aimed here to identify mutations in the PASK gene that may be associated with young-onset diabetes in humans. We screened 18 diabetic probands with unelucidated maturity-onset diabetes of the young (MODY). We identified two rare nonsynonymous mutations in the PASK gene (p.L1051V and p.G1117E), each of which was found in a single MODY family. Wild type or mutant PASKs were expressed in HEK 293 cells. Kinase activity of the affinity-purified proteins was assayed as autophosphorylation at amino acid Thr(307) or against an Ugp1p-derived peptide. Whereas the PASK p.G1117E mutant displayed a similar to 25% increase with respect to wild type PASK in the extent of autophosphorylation, and a similar to 2-fold increase in kinase activity toward exogenous substrates, the activity of the p.L1051V mutant was unchanged. Amino acid Gly(1117) is located in an alpha helical region opposing the active site of PASK and may elicit either: (a) a conformational change that increases catalytic efficiency or (b) a diminished inhibitory interaction with the PAS domain. Mouse islets were therefore infected with adenoviruses expressing wild type or mutant PASK and the regulation of insulin secretion was examined. PASK p.G1117E-infected islets displayed a 4-fold decrease in glucose-stimulated (16.7 versus 3 mM) insulin secretion, chiefly reflecting a 4.5-fold increase in insulin release at low glucose. In summary, we have characterized a rare mutation (p.G1117E) in the PASK gene from a young-onset diabetes family, which modulates glucose-stimulated insulin secretion.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available